Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report released on Thursday morning. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of NYSE:AMPE opened at $0.00 on Thursday. The stock has a 50-day simple moving average of $0.02 and a 200-day simple moving average of $0.43. The stock has a market capitalization of $2,508.00, a P/E ratio of 0.00 and a beta of 3.67. Ampio Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $7.47.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.